iRadimed Corporation (IRMD) is a publicly traded Healthcare sector company. As of May 21, 2026, IRMD trades at $90.40 with a market cap of $1.13B and a P/E ratio of 47.84. IRMD moved +1.82% today. Year to date, IRMD is -8.04%; over the trailing twelve months it is +69.64%. Its 52-week range spans $46.86 to $107.90. Analyst consensus is buy with an average price target of $116.00. Rallies surfaces IRMD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What are IRMD's key financials?
IRMD financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. IRMD recently traded at $90.40. Market cap is $1.13B. P/E ratio is 47.84. Revenue is $86.28M.
IRMD financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. IRMD recently traded at $90.40. Market cap is $1.13B. P/E ratio is 47.84. Revenue is $86.28M.
Is IRMD research on Rallies investment advice?
No. Rallies provides research, data, and educational context for IRMD. It does not provide personalized investment advice.
